Koblinski Anthony

KRMN CEO Anthony Koblinski sold 75,000 shares at $69.31 on 2025-12-12 for $5.2M; recent pattern of 3 sales in 22 days; P/E of 756.22 indicates stretched valuation.

CEO Anthony Koblinski sold 75,000 shares ($5.2M value) on 2025-12-12, bringing holdings to 2.32M shares. This sale is notable as part of a cluster: Koblinski has executed three separate sales in the past 22 days (2025-12-05, 2025-11-28, 2025-11-21 also listed), suggesting sustained disposition activity. At the same ticker (KRMN), his prior two measurable sales (2025-07-25 and 2025-02-14) were both poorly timed—the stock gained +6.6% and +67.3% respectively in the 30 days following—with a timing pattern of 0-for-2 at the 90-day mark. His cross-ticker track record shows similar poor timing (90d well-timed rate of 0.00%; average 90d return after sells was +90.8%, meaning stocks generally rose after his sells). The company's valuation presents context: P/E of 756.22 is extremely elevated relative to net income of $7.6M on $121.8M quarterly revenue (+23.0% annual growth). Stock is currently -21.8% from its 52-week high, down from intra-period peaks, suggesting the recent sellers may have exited during the retreat. Continued insider sales warrant observation given the historically poor timing pattern and outlier valuation metric.

CEO Koblinski sells 75,000 shares of KRMN at $66.51; stock now at $66.06 with P/E of 734.00

CEO Anthony Koblinski sold 75,000 shares (75.0K shares) on 2025-12-05 at $66.51, reducing holdings by 3.0% to 2,390,826 shares (2.39M shares). The stock has declined 6.5% over 30 days and 24.1% from its 52-week high of $87.04, currently trading at $66.06. Of particular note is the company's elevated P/E ratio of 734.00 despite positive fundamentals: revenue of $121,787,000.00 ($121.8M) in the latest quarter with net income of $7,644,000.00 ($7.6M) and annual revenue growth of +23.0%. At this ticker specifically, Koblinski's prior three measurable sales all posted positive 90-day returns (ranging from +6.6% to +102.6%), indicating his recent sales at KRMN have not preceded price declines. The transaction occurs alongside two other recent sales on 2025-11-28 and 2025-11-21 at the same ticker, suggesting a pattern of selling activity in the current environment.

CEO Koblinski sells 75,000 shares at $67.40; stock at $63.71, down 26.8% from 52-week high

CEO Anthony Koblinski sold 75,000 shares (75.0K shares) of KRMN on 2025-11-28 at $67.40, reducing holdings by 3.0% to 2,465,826 shares (2.47M shares). The sale occurred at a price that is now 5.6% above the current market price of $63.71, though the stock has declined 26.8% from its 52-week high of $87.04 and 24.4% over the past 30 days. His prior KRMN trades show a consistent pattern of poorly-timed sells: the 2025-07-25 sale saw the stock rise +67.3% in the following 90 days, and the paired 2025-02-14 sales were followed by +102.6% gains at the 90-day mark, with 0 of 3 prior measurable KRMN sells well-timed on the 90-day metric. The company reports strong fundamentals with $121.8M in latest-quarter revenue and 23.0% annual revenue growth, though the P/E ratio of 707.89 reflects a significant valuation compression relative to earnings. The timing of this sale within a broader post-52-week-high decline warrants monitoring of subsequent price action to assess whether this trade breaks the prior pattern of sales followed by appreciation.

KRMN CEO Koblinski sold 75,000 shares at $58.48; stock now at $63.90, down 26.6% from 52-week high.

CEO Anthony Koblinski sold 75,000 shares (2.9% of his pre-transaction holdings) at $58.48 on 2025-11-21, while the stock now trades at $63.90. Despite the immediate post-sale price increase, the stock has declined 24.1% over the last 30 days and sits 26.6% below its 52-week high of $87.04, suggesting a broader pullback from recent peaks. His prior three sales at KRMN each generated positive 90-day returns (ranging from 6.6% to 102.6%), indicating his historical sales at this ticker preceded subsequent appreciation rather than declines. The company shows solid fundamentals with $121.8M quarterly revenue, 23.0% annual revenue growth, and a $8.5B market cap, though the 710.00 P/E ratio is notably elevated. This sale appears discretionary and occurs against a backdrop of recent downward momentum, yet his historical pattern at this ticker does not support a timing-based explanation for the trade.

CEO Koblinski sells 250,000 shares of KRMN for $12.2M at $49.00 amid negative earnings and elevated valuation.

Anthony Koblinski, Chief Executive Officer, sold 250,000 shares (250.0K shares) of Karman Holdings Inc. for $12,250,000.00 on 2025-07-25 at $49.00 per share, reducing his holdings from 2,865,826 shares to 2,615,826 shares. The sale occurs at a price 4.7% below the current market price of $51.41 and near the upper end of the 52-week range of $26.77–$56.30, though below the 52-week high of $56.30. Critically, Karman's most recent quarter shows Net income of $-4,798,000.00 while maintaining Revenue of $100,124,000.00 and a P/E ratio of 1285.25, reflecting severe profitability stress relative to equity value. Koblinski's prior two trades at KRMN (both on 2025-02-14) experienced positive 90-day returns of +102.6%, meaning the stock rose after those sales—a poorly-timed pattern that did not precede declines. This current sale into an elevated valuation backdrop while the company operates at a net loss warrants monitoring of whether operational performance begins to deteriorate.

CEO Koblinski sold 381,819 shares at $22.00 on 2025-02-14, reducing stake by -11.8% to 2.87M shares post-transaction.

Koblinski Anthony, Chief Executive Officer, executed 2 separate sales totaling 381,819 shares for $8,400,018.00 at $22.00 per share, reducing his holdings from 3.25M shares to 2.87M shares (an -11.8% reduction). The transaction occurred on 2025-02-14, just 4 trading days after KRMN's recent listing, when the stock traded at $22.00. Current price stands at $31.00 as of 2025-02-19, representing a $9.00 per-share increase since the CEO's sale date. The substantial liquidation of over 380K shares by the company's top executive in the early post-IPO window, combined with the sharp subsequent price appreciation, warrants investor attention regarding the CEO's valuation view at the time of execution and the composition of his remaining 2.87M-share position.